Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Biomarkers / IL8



This biomarker is also known as:
  • Emoctakin,
  • neutrophil-activating peptide 1,
  • LYNAP,
  • GCP-1,
  • small inducible cytokine subfamily B, member 8,
  • T cell chemotactic factor,
  • lymphocyte-derived neutrophil-activating factor,
  • LUCT,
  • OTTHUMP00000199825,
  • 3-10C,
  • Protein 3-10C,
  • CXCL8,
  • NAP1,
  • GCP1,
  • NAP-1,
  • MONAP,
  • beta-thromboglobulin-like protein,
  • NAF,
  • C-X-C motif chemokine 8,
  • interleukin 8,
  • T-cell chemotactic factor,
  • interleukin-8,
  • Granulocyte chemotactic protein,
  • LECT,
  • AMCF-I,
  • Neutrophil-activating protein 1,
  • Monocyte-derived neutrophil-activating peptide,
  • IL-8,
  • chemokine (C-X-C motif) ligand 8,
  • MDNCF,
  • emoctakin,

View in BioMuta


Interleukin 8 (IL8) is a member of the CXC chemokine family. This chemokine functions as a chemoattractant, or chemotactic factor, that attracts neutrophils, basophils, and T-cells, but not monocytes. IL8 is one of the major mediators of the inflammatory response, and is involved in neutrophil activation. It is released from several types of cells in response to an inflammatory stimulus. IL8 also functions as an angiogenic factor. The IL8 gene maps to chromosome 4q, and is found in a chemokine gene cluster along with ten other members of the CXC chemokine gene family. There are several N-terminal processed forms that are produced by proteolytic cleavage after secretion from at least peripheral blood monocytes, leukcocytes and endothelial cells. Among the forms are: IL-8(1-77), IL-8(5-77), IL-8(6-77), IL-8(7-77), IL-8(8-77), IL-8(9-77). IL-8(1-77) is generally referred to as interleukin 8. IL-8(6-77) is the most promiment form.


QA State: Curated
Type: Protein
Short Name:
HGNC Name: IL8


There are no datasets associated with this biomarker.


The following organs have data associated with this biomarker…



Phase: Two
QA State: Under Review


Performance Comment

Levels of IL8 in exhaled breath condensate indicated acute inflammation but were not indicative of lung cancer.



Phase: Two
QA State: Under Review


IL8 alone was not shown to be a strong predictor of ovarian cancer.

Performance Comment

Despite many promising new markers for ovarian cancer, CA125 remains the single best biomarker in the phase II and phase III specimens tested in this study.



Phase: One
QA State: Under Review


Performance Comment


This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at if you should have access to this biomarker.

Announcement 10/07/2014

EDRN Patient Advocates will host an EDRN Advocacy Educational Webinar, Biomarkers for Prostate Cancer Detection and Monitoring, on Monday, January 12th, 2015, at 1 p.m. EDT / 10 a.m. PDT. Registration is not required for this. Please click for more information.
Announcement 09/14/2014

Thank you to everyone who helped make the 9th EDRN Scientific Workshop a success. We look forward to seeing everyone at the 28th EDRN Steering Committee Meeting from March 31-April 2, 2015, in Atlanta, GA.